Furthermore, we conducted in vivo treatment of TM00091 PDX tumours, which carry two BRCA1 point mutations (Q356R and C61G), with NOTCH1 hyperactivation (Supplementary Fig. 10a). This evidence concerns the gene BRCA1 and neoplasm.